Today's News | Note: News feeds may no longer be available for the articles on this page.

J&J, Schering-Plough get arthritis drug approval 5:32 PM 4/13/2009
Forbes - NY,USA
Schering-Plough Corp and a Johnson & Johnson unit won first approval from Canadian regulators for Simponi (golimumab) for moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. ...

New type of cancer trial may speed drug discovery 12:46 PM 4/13/2009
Reuters - USA
The first-ever Phase 0 trial run on an Abbott Laboratories Inc cancer pill showed it was safe and suggested it may work against a range of advanced cancers. ...

New Drug Could Help Wipe Out Scars 10:27 AM 4/10/2009
FOXNews - USA
The drug avotermin has the potential to reduce scarring when administered before a surgical operation or on existing scars. ...

FDA Reverses Stance on Removal of Morphine Painkiller 6:28 AM 4/10/2009
Forbes - NY,USA
In another example of how clueless the US FDA is to patient needs and bowing to pleas from hospice experts, the agency backs off its intent to remove unapproved liquid morphine painkiller given to dying patients. ...

Sanofi to Buy Brazil's Medley 5:41 AM 4/9/2009
Wall Street Journal - USA
Sanofi-Aventis plans to buy Brazil's Medley to become Latin America's top generic drug manufacturer following the purchase Laboratorios Kendrick in Mexico. ...

Takeda Buys Actos Diabetes-Drug Rights From Lilly 3:21 AM 4/9/2009
Bloomberg - USA
Takeda Pharmaceutical Co bought back the rights to its best-selling diabetes drug Actos in seven countries from Eli Lilly & Co. ...

Merck licenses heart drug from Cardiome, shrs jump 5:29 PM 4/8/2009
Reuters - USA
Merck & Co Inc licensed experimental heart drug vernakalant for treatment of atrial fibrillation from Cardiome Pharma Corp for $60 million and additional milestone payments. ...

Lilly osteoporosis drug passes new test 2:56 PM 4/8/2009
Reuters - USA
Eli Lilly and Co's experimental osteoporosis drug arzoxifene has achieved its primary goals in a late-stage clinical trial in postmenopausal women. ...

Roche's Genentech pulls psoriasis drug from US market 2:06 PM 4/8/2009
MarketWatch - USA
Roche Holding Ltd's recently acquired Genentech Inc pulled its psoriasis drug Raptiva from the US market because of its association with often fatal neurological condition progressive multifocal leukoencephalopathy (PML). ...

Takeda cancer drug slows tumor growth in mice 12:05 PM 4/8/2009
Reuters - USA
An experimental cancer drug developed by Takeda Pharmaceutical Co's recently acquired Millennium Pharmaceuticals unit suppressed tumor cell growth in human lung tissue that had been transplanted into mice ...

US clears Novartis malaria drug, awards voucher 11:37 AM 4/8/2009
Reuters - USA
The US FDA has approved Novartis' Coartem to treat acute uncomplicated malaria infections in adults and children weighing over 11 pounds. ...

Ahead of the Bell: FDA weighs Seroquel 5:13 AM 4/8/2009
Forbes - NY,USA
AstraZeneca's Seroquel posted sales of $4.5 billion last year approved to treat schizophrenia and bipolar disorder. FDA is asked to approve it for patients with depression and anxiety disorder. ...

US panel backs Lundbeck drug for some schizophrenics 4:11 PM 4/7/2009
Reuters - USA
A US advisory panel voted 8-2 to recommend that H Lundbeck's Serdolect be available for certain patients despite concerns about heart-related risks. ...

Medivation prostate drug shows promise-study 2:56 PM 4/7/2009
Reuters - USA
Medivation Inc's MDV3100 in a phase I/II clinical trial showed sustained declines in serum levels of prostate specific antigen which is a biomarker of prostate cancer. ...

Pfizer plans two research chiefs upon Wyeth merger 8:01 AM 4/7/2009
Reuters - USA
Pfizer Inc will have one research chief in charge of traditional medicines and one in charge of biotech drugs and vaccines when it completes its planned purchase of Wyeth. ...

<- Day Earlier | Today's News